$43.19
-0.33-0.76%
At close: Jun 18, 5:00 PM EST
$43.10
-0.09-0.21%
After Hours: Jun 18, 7:58 PM EST
Novo Nordisk AS Earnings Estimates
NVONYSE
Novo Nordisk Earnings Estimates, EPS & Revenue | NYSE:NVO
Novo Nordisk (NVO) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $0.83 and quarterly revenue of $11.35B.
In the most recent quarter (Q1), Novo Nordisk reported EPS of $1.04, beating estimates of $0.87 by 0.19%. Revenue came in at $15.17B, exceeding the estimate of $11.13B by 0.36%.
Novo Nordisk has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Novo Nordisk has averaged an EPS surprise of 0.17% and a revenue surprise of 0.10%.
Earnings Date
Aug 5
EPS Estimate
$0.830
Quarterly Revenue Estimate
$11.35B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$327.80B
Novo Nordisk Earnings History
Analyze the earnings history of Novo Nordisk using advanced sorting and filters.
Loading calendar...
Novo Nordisk (NVO) Earnings Per Share
The chart below shows Novo Nordisk's reported EPS compared to analyst estimates over recent quarters.
Novo Nordisk (NVO) Revenue
The chart below shows Novo Nordisk's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Novo Nordisk (NYSE:NVO) reporting earnings?
Novo Nordisk (NVO) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 6, 2026 for Q1.
What were the latest earnings per share (EPS) for Novo Nordisk (NYSE:NVO)?
The Actual EPS was $1.04, which beat the estimate of $0.87.
What were Novo Nordisk’s (NYSE:NVO) revenues?
The Actual Revenue was $15.17B, which beat the estimate of $11.13B.
